Small Molecules
3 October 2018
Genentech Announces New Data for Risdiplam in Spinal Muscular Atrophy (SMA) at the World Muscle Society Congress3 October 2018
Paratek Announces FDA Approval of NUZYRA™ (Omadacycline)2 October 2018
CANbridge Pharmaceutical Submits New Drug Application for NERLYNX® (neratinib) in China30 September 2018
Eisai Announces FDA Approval Of FYCOMPA® in Pediatric Patients As Young As 4 Years Old For The Treatment Of Partial-Onset Seizures30 September 2018
TransThera Biosciences Granted IND Approval from FDA to Soon Start Clinical Trials Targeting TNBC30 September 2018
Orphazyme reports encouraging arimoclomol clinical trial top-line data in Niemann-Pick disease Type C (NPC)28 September 2018
U.S. FDA Approves VIZIMPRO® (dacomitinib) for the First-Line Treatment of Patients with EGFR-Mutated Metastatic Non-Small Cell Lung Cancer27 September 2018
Trevi Therapeutics Initiates Pivotal Clinical Trial of Nalbuphine® ER for the Treatment of Pruritus in Prurigo Nodularis27 September 2018
Cidara Therapeutics Initiates Phase 3 Trial of Lead Antifungal Rezafungin for Treatment of Invasive Candida Infections27 September 2018
FLX Bio Announces First Patient Dosed With FLX475, a Best-in-Class CCR4 Inhibitor for the Treatment of Multiple Cancers27 September 2018
Janssen Elects Not to Continue Agreement with Geron for Imetelstat26 September 2018
Allergan Announces FDA Acceptance of Supplemental New Drug Application For VRAYLAR® (cariprazine)26 September 2018
Cerevance Announces First-in-Human Dosing of CVN424 for the Treatment of Parkinson’s Disease26 September 2018
VenatoRx Pharmaceuticals and Everest Medicines II Limited Announce Exclusive License Agreement for cefepime/VNRX-513326 September 2018
Catabasis Pharmaceuticals Initiates Phase 3 PolarisDMD Clinical Trial for Edasalonexent in Duchenne Muscular Dystrophy26 September 2018
Checkpoint Therapeutics Announces Presentation of Updated Data from Phase 1/2 Trial of EGFR Inhibitor CK-101News Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
SubscribeNewsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
SubscribeFeatured reports